KYTX · Kyverna Therapeutics, Inc.

$8.49 +0.12 (+1.43%) At close · Aug 31

Russell 2000 member Rebalance outlook locked

Market Cap

$517.63M

61.84M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-05-19	H.C. Wainwright 4th Annual Nasdaq BioConnect Conference	Conference
2026-04-22	Kyverna AAN Conference Call	Conference
2026-04-22	Earnings conference call (announced in 8-K)	Earnings call
2026-03-09	Leerink Global Healthcare Conference	Conference
2026-01-14	J.P. Morgan 2026 Healthcare Conference	Conference
2025-12-15	KYSA-8 Topline Results for Stiff Person Syndrome	Earnings call
2025-11-17	Jefferies Global Healthcare Conference	Conference
2025-10-29	Kyverna Conference Call - KYSA-6 Phase 2 Interim Results for Myasthenia Gravis (MG)	Earnings call
2025-09-09	H.C. Wainwright 27th Annual Global Investment Conference	Conference
2025-09-08	Morgan Stanley 23rd Annual Global Healthcare Conference	Conference
2025-09-03	2025 Wells Fargo Healthcare Conference	Conference
2025-08-28	Virtual KOL Event - A Spotlight on Kyverna's Neuroimmunology CAR T Franchise	Event
2025-06-04	Jefferies Global Healthcare Conference	Conference
2025-03-10	Kyverna Therapeutics at Leerink Global Healthcare Conference	Conference
2025-01-14	Kyverna Therapeutics at J.P. Morgan Healthcare Conference	Conference

Source: https://ir.kyvernatx.com/

Key facts CIK 1994702 CUSIP 501976104 13F (30d) 100 filings 100 filers Visit website Investor relations